免疫球蛋白类转换
免疫球蛋白D
生物
慢性淋巴细胞白血病
分子生物学
胞苷脱氨酶
体细胞突变
CD5型
体内
抗体
B细胞
癌症研究
白血病
免疫学
遗传学
作者
Andrea Cerutti,Hong Zan,Edmund C. Kim,Shefali Shah,Elaine J. Schattner,András Schaffer,Paolo Casali
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2002-12-01
卷期号:169 (11): 6594-6603
被引量:71
标识
DOI:10.4049/jimmunol.169.11.6594
摘要
Chronic lymphocytic leukemia (CLL) results from the expansion of malignant CD5(+) B cells that usually express IgD and IgM. These leukemic cells can give rise in vivo to clonally related IgG(+) or IgA(+) elements. The requirements and modalities of this process remain elusive. Here we show that leukemic B cells from 14 of 20 CLLs contain the hallmarks of ongoing Ig class switch DNA recombination (CSR), including extrachromosomal switch circular DNAs and circle transcripts generated by direct S micro -->Sgamma, S micro -->Salpha, and S micro -->Sepsilon as well as sequential Sgamma-->Salpha and Sgamma-->Sepsilon CSR. Similar CLL B cells express transcripts for activation-induced cytidine deaminase, a critical component of the CSR machinery, and contain germline I(H)-C(H) and mature V(H)DJ(H)-C(H) transcripts encoded by multiple Cgamma, Calpha, and Cepsilon genes. Ongoing CSR occurs in only a fraction of the CLL clone, as only small proportions of CD5(+)CD19(+) cells express surface IgG or IgA and lack IgM and IgD. In vivo class-switching CLL B cells down-regulate switch circles and circle transcripts in vitro unless exposed to exogenous CD40 ligand and IL-4. In addition, CLL B cells that do not class switch in vivo activate the CSR machinery and secrete IgG, IgA, or IgE upon in vitro exposure to CD40 ligand and IL-4. These findings indicate that in CLL at least some members of the malignant clone actively differentiate in vivo along a pathway that induces CSR. They also suggest that this process is elicited by external stimuli, including CD40 ligand and IL-4, provided by bystander immune cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI